Evidence map›Paper›PMID 41096245›Full record

ReviewPolymers2025

Biobased Polyamides: A Journey from the Biomass Towards Cutting Edge Materials.

Maria Diaz-Galbarriatu, Julia Sánchez-Bodón, Estíbaliz Hernáez-Laviña, José Luis Vilas-Vilela, Isabel Moreno-Benítez

Abstract readReview
In one paragraph

Review in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maria Diaz-GalbarriatuInnovative Macromolecular Materials (IMACROMAT), Department of Physical Chemistry, UPV/EHU, 48940 Leioa, Spain.
Julia Sánchez-BodónInnovative Macromolecular Materials (IMACROMAT), Department of Physical Chemistry, UPV/EHU, 48940 Leioa, Spain.ORCID 0000-0002-3576-1526
Estíbaliz Hernáez-LaviñaInnovative Macromolecular Materials (IMACROMAT), Department of Physical Chemistry, UPV/EHU, 48940 Leioa, Spain.
José Luis Vilas-VilelaInnovative Macromolecular Materials (IMACROMAT), Department of Physical Chemistry, UPV/EHU, 48940 Leioa, Spain.
Isabel Moreno-BenítezInnovative Macromolecular Materials (IMACROMAT), Department of Organic and Inorganic Chemistry, UPV/EHU, 48940 Leioa, Spain.ORCID 0000-0001-8714-9120

Funding

Basque Government IT-1756-22
6 · The paper itself

Abstract

Since the 1930s, polyamides (PAs) have become increasingly vital across industries like automotive, textiles, electronics, and packaging, owing to their exceptional properties. However, they also have notable limitations, including a tendency to absorb water, low dimensional stability, poor solubility, and the resulting processing challenges. From an environmental perspective, the reliance on fossil-based monomers for traditional PAs and the accumulation of post-consumer waste, due to their resistance to (bio)degradation, are key concerns. In recent decades, significant advancements have been made in synthesizing PAs from bio-based monomers, primarily sourced from inedible lignocellulosic materials. Some of these bio-based PAs exhibit properties comparable to their fossil-derived counterparts, with benefits like enhanced solubility, which simplifies processing. Moreover, certain bio-based variants have shown improved biodegradability, facilitating the potential recovery of monomers for the production of new virgin polymers and reducing waste accumulation. This review highlights the progress in developing PAs from commonly used bio-based sources, including lignin-derived aromatic compounds, terpenes, fatty acids, and furan derivatives, with a focus on the improvements made over their fossil-based analogs.

Indexed as

biobasedfatty acidsfuranpolyamidesterpene

Identifiers

PMID41096245
PMCPMC12526697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.